Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis-Reference-Cited by-同舟云学术

Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis

Published:2010-03 Issue:3 Volume:30 Page:430-437
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Zachou Kalliopi,Yurdaydin Cihan,Drebber Uta,Dalekos George N.,Erhardt Andreas,Cakaloglu Yilmaz,Degertekin Halil,Gurel Selim,Zeuzem Stefan,Bozkaya Hakan,Schlaphoff Verena,Dienes Hans P.,Bock Thomas C.,Manns Michael P.,Wedemeyer Heiner,

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2009.02140.x/fullpdf

Reference38 articles.

1. 1. Farci P. Delta hepatitis: an update. J Hepatol 2003; 39 (Suppl. 1): S212-9.

2. 2. Sagnelli E , Felaco FM , Filippini P , et al. Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis. Liver 1989; 9: 229-34.

3. 3. Fattovich G , Giustina G , Christensen E , et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European concerted action on viral hepatitis (Eurohep). Gut 2000; 46: 420-6.

4. 4. Rizzetto M. The delta agent. Hepatology 1983; 3: 729-37.

5. 5. Taylor JM. Hepatitis delta virus. Virology 2006; 344: 71-6.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predominance of Genotype 5 Hepatitis Delta Virus Infection in a Portuguese Hepatology Unit;Livers;2024-08-21

2. Prevalence, characteristics, and virologic correlations of hepatitis delta (D) among patients with hepatitis B surface antigen in Mongolia;Global Health & Medicine;2024-04-30

3. Diagnosis and therapy of chronic hepatitis D: Czech national guidelines. The date of release: 2023;Vnitřní lékařství;2023-12-18

4. Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS);Zeitschrift für Gastroenterologie;2023-12

5. Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS);Zeitschrift für Gastroenterologie;2023-12